ANXA8

Across TCGA pan-cancer cohorts, ANXA8 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ANXA8’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where ANXA8 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ANXA8 is over-expressed in tumor, although a few such as LUAD and HNSC show the opposite, repressed pattern.

LSCC, LUAD, and PDAC are the cancer types where ANXA8 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANXA8 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Female	All	+2.289	<.001	9	view →
LUAD	Female	All	−1.189	<.001	8	view →
PDAC	All	All	+1.163	<.001	6	view →
CCRCC	All	All	+0.852	.009	2	view →
HNSC	Male	IV	−0.695	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ANXA8–LSCC

Open the LSCC breakdown →